BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng XQ, Huang JF, Lin JL, Chen L, Zhou TT, Chen D, Lin DD, Shen JF, Wu AM. Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study. Transl Lung Cancer Res 2019;8:367-79. [PMID: 31555512 DOI: 10.21037/tlcr.2019.08.16] [Cited by in Crossref: 13] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhou L, Zhang Y, Chen W, Niu N, Zhao J, Qi W, Xu Y. Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: a study based on the SEER database and a Chinese cohort. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-10067-8] [Reference Citation Analysis]
2 Luo L, Lin H, Huang J, Lin B, Huang F, Luo H. Risk factors and prognostic nomogram for patients with second primary cancers after lung cancer using classical statistics and machine learning. Clin Exp Med 2022. [PMID: 35821159 DOI: 10.1007/s10238-022-00858-5] [Reference Citation Analysis]
3 Zhu Y, Chang X, Zhou R, Chen Y, Ma H, Xiao Z, Qu X, Liu Y, Liu L, Li Y, Yu Y, Zhang H. Bone Metastasis Attenuates Efficacy of Immune Checkpoint Inhibitors and Displays “Cold” Immune Characteristics in Non-small Cell Lung Cancer. Lung Cancer 2022. [DOI: 10.1016/j.lungcan.2022.03.006] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Hu S, Zhang W, Guo Q, Ye J, Zhang D, Zhang Y, Zeng W, Yu D, Peng J, Wei Y, Xu J. Prognosis and Survival Analysis of 922,317 Lung Cancer Patients from the US Based on the Most Recent Data from the SEER Database (April 15, 2021). Int J Gen Med 2021;14:9567-88. [PMID: 34916838 DOI: 10.2147/IJGM.S338250] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Congedo MT, Nachira D, Bertolaccini L, Chiappetta M, Zanfrini E, Meacci E, Vita ML, Lococo F, D'Argento E, Spaggiari L, Margaritora S. Multimodal therapy for synchronous bone oligometastatic NSCLC: The role of surgery. J Surg Oncol 2021. [PMID: 34918785 DOI: 10.1002/jso.26773] [Reference Citation Analysis]
6 Dong Q, Deng J, Mok TN, Chen J, Zha Z. Construction and Validation of Two Novel Nomograms for Predicting the Overall Survival and Cancer-Specific Survival of NSCLC Patients with Bone Metastasis. Int J Gen Med 2021;14:9261-72. [PMID: 34880665 DOI: 10.2147/IJGM.S342596] [Reference Citation Analysis]
7 Li Z, Wei J, Cao H, Song M, Zhang Y, Jin Y. A predictive web-based nomogram for the early death of patients with lung adenocarcinoma and bone metastasis: a population-based study. J Int Med Res 2021;49:3000605211047771. [PMID: 34590874 DOI: 10.1177/03000605211047771] [Reference Citation Analysis]
8 Qi Y, Wu S, Tao L, Shi Y, Yang W, Zhou L, Zhang B, Li J. Development of Nomograms for Predicting Lymph Node Metastasis and Distant Metastasis in Newly Diagnosed T1-2 Non-Small Cell Lung Cancer: A Population-Based Analysis. Front Oncol 2021;11:683282. [PMID: 34568016 DOI: 10.3389/fonc.2021.683282] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Xue M, Chen G, Chen X, Hu J. Predictors for survival in patients with bone metastasis of small cell lung cancer: A population-based study. Medicine (Baltimore) 2021;100:e27070. [PMID: 34449503 DOI: 10.1097/MD.0000000000027070] [Reference Citation Analysis]
10 Dai L, Wang W, Liu Q, Xia T, Wang Q, Chen Q, Zhu N, Cheng Y, Yan Y, Shu J, Qu K. Development and validation of prognostic nomogram for lung cancer patients below the age of 45 years. Bosn J Basic Med Sci 2021;21:352-63. [PMID: 33091332 DOI: 10.17305/bjbms.2020.5079] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Wu X, Wang Y, Sun W, Tan M. Prognostic Factors and a Nomogram Predicting Overall Survival in Patients with Limb Chondrosarcomas: A Population-Based Study. Biomed Res Int 2021;2021:4510423. [PMID: 34055971 DOI: 10.1155/2021/4510423] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Wu LL, Chen WT, Liu X, Jiang WM, Huang YY, Lin P, Long H, Zhang LJ, Ma GW. A Nomogram to Predict Long-Term Survival Outcomes of Patients Who Undergo Pneumonectomy for Non-small Cell Lung Cancer With Stage I-IIIB. Front Surg 2021;8:604880. [PMID: 33996882 DOI: 10.3389/fsurg.2021.604880] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Botticelli A, Cirillo A, Pomati G, Cerbelli B, Scagnoli S, Roberto M, Gelibter A, Mammone G, Calandrella ML, Cerbelli E, Di Pietro FR, De Galitiis F, Lanzetta G, Cortesi E, Mezi S, Marchetti P. The role of opioids in cancer response to immunotherapy. J Transl Med 2021;19:119. [PMID: 33757546 DOI: 10.1186/s12967-021-02784-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yu X, Gao S, Xue Q, Tan F, Gao Y, Mao Y, Wang D, Zhao J, Li Y, Wang F, Cheng H, Zhao C, Mu J. Development of a nomogram for predicting the operative mortality of patients who underwent pneumonectomy for lung cancer: a population-based analysis. Transl Lung Cancer Res 2021;10:381-91. [PMID: 33569320 DOI: 10.21037/tlcr-20-561] [Reference Citation Analysis]
15 Wu S, Pan Y, Mao Y, Chen Y, He Y. Current progress and mechanisms of bone metastasis in lung cancer: a narrative review. Transl Lung Cancer Res 2021;10:439-51. [PMID: 33569325 DOI: 10.21037/tlcr-20-835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
16 Zhang J, Xu J, Jin S, Gao W, Guo R, Chen L. The development and validation of a nomogram for predicting brain metastases in lung squamous cell carcinoma patients: an analysis of the Surveillance, Epidemiology, and End Results (SEER) database. J Thorac Dis 2021;13:270-81. [PMID: 33569207 DOI: 10.21037/jtd-20-3494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Qiu B, Li G, Luo F, Cai X, Wu L, Chen J, Hu Y, Tang Z, Yang S, He J. Treatment patterns, clinical outcomes, and healthcare resource use associated with advanced/metastatic lung cancer in China: protocol for a retrospective observational study. Transl Lung Cancer Res 2020;9:2460-8. [PMID: 33489806 DOI: 10.21037/tlcr-20-1269] [Reference Citation Analysis]
18 Ryan C, Stoltzfus KC, Horn S, Chen H, Louie AV, Lehrer EJ, Trifiletti DM, Fox EJ, Abraham JA, Zaorsky NG. Epidemiology of bone metastases. Bone 2020;:115783. [PMID: 33276151 DOI: 10.1016/j.bone.2020.115783] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
19 Deng F, Zhou H, Lin Y, Heim JA, Shen L, Li Y, Zhang L. Predict multicategory causes of death in lung cancer patients using clinicopathologic factors. Comput Biol Med 2021;129:104161. [PMID: 33307409 DOI: 10.1016/j.compbiomed.2020.104161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
20 Wang HL, Wang HR, Liang Y, Hu AN, Enguita FJ, Zhou XG, Dong J. Hsa_circ_0006571 promotes spinal metastasis through sponging microRNA-138 to regulate sirtuin 1 expression in lung adenocarcinoma. Transl Lung Cancer Res 2020;9:2411-27. [PMID: 33489803 DOI: 10.21037/tlcr-20-1250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
21 Kniese CM, Musani AI. Bronchoscopic treatment of inoperable nonsmall cell lung cancer. Eur Respir Rev 2020;29:200035. [PMID: 33153988 DOI: 10.1183/16000617.0035-2020] [Reference Citation Analysis]
22 Wang H, Hu A, Liang Y, Wang K, Zhou X, Dong J. Genome-wide analysis of long non-coding RNA expression profile in lung adenocarcinoma compared to spinal metastasis. Ann Transl Med 2020;8:1516. [PMID: 33313261 DOI: 10.21037/atm-20-7046] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Liu Y, Li X, Yin Z, Lu P, Ma Y, Kai J, Luo B, Wei S, Liang X. Prognostic Prediction Models Based on Clinicopathological Indices in Patients With Resectable Lung Cancer. Front Oncol 2020;10:571169. [PMID: 33194667 DOI: 10.3389/fonc.2020.571169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 McCabe FJ, Jadaan DY, Jadaan MM, McCabe JP. The rise of metastatic bone disease in Ireland. Clin Exp Metastasis 2020;37:693-702. [PMID: 33099723 DOI: 10.1007/s10585-020-10059-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Tong Y, Huang Z, Hu C, Chi C, Lv M, Li P, Zhao C, Song Y. Independent risk factors evaluation for overall survival and cancer-specific survival in thyroid cancer patients with bone metastasis: A study for construction and validation of the predictive nomogram. Medicine (Baltimore) 2020;99:e21802. [PMID: 32899008 DOI: 10.1097/MD.0000000000021802] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
26 Huang Z, Hu C, Chi C, Jiang Z, Tong Y, Zhao C. An Artificial Intelligence Model for Predicting 1-Year Survival of Bone Metastases in Non-Small-Cell Lung Cancer Patients Based on XGBoost Algorithm. Biomed Res Int 2020;2020:3462363. [PMID: 32685470 DOI: 10.1155/2020/3462363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]